Friday 6 November 2026 Export GEHC’s income statement to Excel — free account

GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.

Revenue: +7.19%
EPS: +40.6%
Free cash flow: +64.2%
Total debt: −1.90%

Quarter to September 2026, against a year earlier

82.81 0.94 −1.12%

Follow GEHC

Alert me

Market cap: $37.9B
P/E: 17.5×
Fwd P/E: 15.5×
Dividend yield: 0.17%
F-score: 4/9
Altman Z: 1.96
Beneish M: −2.33
Dividend safety: 74/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

GE HealthCare Technologies Inc. (GEHC) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Imaging	9,245	44.82%
AVS	5,354	25.96%
PCS	3,086	14.96%
PDx	2,900	14.06%
Gross margin		39.99%
Operating margin		13.39%
Pre-tax margin		13.42%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Product	13,661 66.24%	13,075 66.47%	13,127 67.14%	12,044 65.67%	11,165 63.49%
Service	6,964 33.76%	6,597 33.53%	6,425 32.86%	6,297 34.33%	6,420 36.51%
Revenue	20,625	19,672	19,552	18,341	17,585

Gross profit by product or service $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021
Product	‡	‡	‡	‡	‡
Service	‡	‡	‡	‡	‡
Gross profit	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Imaging	9,245 44.82%	8,855 45.01%	8,944 45.74%	8,395 45.77%	9,433 53.64%
AVS	5,354 25.96%	5,131 26.08%	5,094 26.05%	5,012 27.33%	—
PCS	3,086 14.96%	3,125 15.89%	3,142 16.07%	2,916 15.90%	2,915 16.58%
PDx	2,900 14.06%	2,508 12.75%	2,306 11.79%	1,958 10.68%	2,018 11.48%
Ultrasound	—	—	—	—	3,172 18.04%
Revenue	20,625	19,672	19,552	18,341	17,585

Gross profit by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021
Imaging	‡	‡	‡	‡	‡
AVS	‡	‡	‡	‡	‡
PCS	‡	‡	‡	‡	‡
PDx	‡	‡	‡	‡	‡
Gross profit	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021
All other countries	9,427 45.71%	8,919 45.34%	8,764 44.82%	8,197 44.69%	8,015 45.58%
United States	9,168 44.45%	8,617 43.80%	8,228 42.08%	7,819 42.63%	7,060 40.15%
China	2,031 9.85%	2,135 10.85%	2,560 13.09%	2,325 12.68%	2,510 14.27%
Revenue	20,625	19,672	19,552	18,341	17,585

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Backlog	Q3 FY2026	$23.7B	—	—
Organic orders growth	Q3 FY2026	4.00%	6.00%	—
Remaining performance obligations	Q1 FY2026	$15.8B	$14.9B	+6.38%
Total company book-to-bill	Q3 FY2026	1.0×	1.1×	−2.83%

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023	Q2 FY2023	Q1 FY2023
Backlog	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Organic orders growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Remaining performance obligations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Total company book-to-bill	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.